K George Chandy Selected Research

K George Chandy Research Topics

Disease

11	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 09/2003
9	Multiple Sclerosis 01/2021 - 06/2004
7	Neoplasms (Cancer) 02/2022 - 07/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2012 - 08/2005
3	Hypersensitivity (Allergy) 09/2012 - 01/2007
3	Rheumatoid Arthritis 09/2012 - 11/2006
2	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2019
2	Heart Diseases (Heart Disease) 01/2020 - 01/2002
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 03/2013
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2017 - 01/2017
2	Arthritis (Polyarthritis) 09/2012 - 11/2006
1	Colonic Neoplasms (Colon Cancer) 02/2022
1	Fibrosis (Cirrhosis) 01/2020
1	Pain (Aches) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Brain Injuries (Brain Injury) 04/2014
1	Insulin Resistance 06/2013
1	Fatty Liver 06/2013
1	Weight Gain 06/2013
1	Melanoma (Melanoma, Malignant) 07/2012
1	Demyelinating Diseases (Demyelinating Disease) 01/2011
1	Opportunistic Infections (Opportunistic Infection) 08/2009
1	Atherosclerosis 09/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2008
1	Chronic Disease (Chronic Diseases) 01/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2006
1	Diabetes Mellitus 11/2006
1	Cardiotoxicity 04/2005
1	Body Weight (Weight, Body) 06/2004
1	Cerebellar Ataxia (Dysmetria) 02/2004
1	Hyperplasia 09/2003
1	Heart Block 01/2002
1	Hereditary bundle branch system defect 01/2002

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 06/2017 - 04/2005
4	AntigensIBA 08/2020 - 01/2007
3	Pharmaceutical PreparationsIBA 01/2020 - 09/2012
3	Ion Channels (Ion Channel)IBA 01/2020 - 01/2002
3	PotassiumIBA 01/2016 - 04/2014
3	Potassium Channels (Potassium Channel)IBA 08/2009 - 12/2005
2	CholesterolIBA 06/2013 - 09/2008
2	pristane (pristan)IBA 09/2012 - 11/2006
2	5-(4-phenylbutoxy)psoralenIBA 07/2012 - 06/2004
2	Immunologic Factors (Immunomodulators)IBA 03/2012 - 06/2004
2	TRAM 34IBA 09/2008 - 09/2003
2	AutoantigensIBA 10/2007 - 06/2004
2	Myelin Basic ProteinIBA 10/2007 - 01/2007
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 08/2005 - 01/2002
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 02/2022
1	Immune Checkpoint InhibitorsIBA 02/2022
1	CalciumIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	PlatinumIBA 01/2018
1	Insulin (Novolin)FDA Link 06/2013
1	SugarsIBA 06/2013
1	LeptinIBA 06/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Therapeutic UsesIBA 09/2012
1	Clofazimine (Lamprene)FDA Link 07/2012
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2012
1	ShK neurotoxinIBA 03/2012
1	EnzymesIBA 01/2011
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2011
1	Interleukin-7 (Interleukin 7)IBA 01/2011
1	CTLA-4 AntigenIBA 01/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	Cholecalciferol (Vitamin D3)FDA Link 01/2011
1	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 09/2008
1	Apolipoproteins E (ApoE)IBA 09/2008
1	Clotrimazole (Lotrimin)FDA LinkGeneric 09/2008
1	EmulsionsIBA 01/2007
1	Kv1.3 Potassium ChannelIBA 11/2006
1	Riluzole FDA LinkGeneric 02/2004
1	Neuroprotective AgentsIBA 02/2004
1	CollagenIBA 09/2003
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 09/2003
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 09/2003

Therapy/Procedure

15	Therapeutics 01/2020 - 09/2003
3	Immunomodulation 01/2019 - 04/2005
1	Immunotherapy 01/2017
1	Radiotherapy 04/2014
1	Intraperitoneal Injections 07/2012
1	Subcutaneous Injections 06/2004
1	Catheters 09/2003